Harmony Biosciences Holdings, Inc. (HRMY)
29.19
-0.10
(-0.34%)
USD |
NASDAQ |
Apr 15, 16:00
29.72
+0.53
(+1.82%)
After-Hours: 20:00
Harmony Biosciences Holdings Research and Development Expense (Annual) : 189.59M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Castle Biosciences, Inc. | 51.50M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Amicus Therapeutics, Inc. | 135.84M |
| Iovance Biotherapeutics, Inc. | 300.27M |
| Apellis Pharmaceuticals, Inc. | 295.85M |